Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

NCT05536414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Centanafadine
DRUG: Escitalopram
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.